Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Kee Sup Song, M.D., Min Ju Kim, M.D., Chang Soo Jang, M.D., Hyuk Sang Jung, M.D., Hyun Hee Lee, M.D., Oh Sang Kwon, M.D., Yun Soo Kim, M.D., Duck Joo Choi, M.D., Ju Hyun Kim, M.D., Seung Yeon Ha, M.D.

Clin Mol Hepatol. 2007;13(2):166-173. Published online January 1, 1970

View: 3314 Download: 35

The Adverse Effect of Indirectly Diagnosed Portal Hypertension on the Complications and Prognosis after Hepatic Resection of Hepatocellular Carcinoma

Min An , Joong Won Park , Jeong A Shin , Joon Il Choi , Tae Hyun Kim , Seong Hoon Kim , Woo Jin Lee , Sang Jae Park , Eun Kyoung Hong , Chang Min Kim

Clin Mol Hepatol. 2006;12(4):553-561. Published online January 1, 1970

View: 2735 Download: 17

1

Preoperative Evaluation and Postoperative Complications with Prognostic Impact of Surgical Resection for the Hepatocellular Carcinoma in Cirrhotics

Koo Jeong Kang

Clin Mol Hepatol. 2006;12(4):479-483. Published online January 1, 1970

View: 2211 Download: 16

4

A Case of Bell`s Palsy Associated with Peginterferon Alfa-2a and Ribavirin Therapy for Chronic Hepatitis C Virus Infection

Moo Yeol Lee, M.D., Hoon Cho, M.D., Yeong Muk Kim, M.D., and Joon Sang Lee, M.D.

Clin Mol Hepatol. 2006;12(3):444-448. Published online January 1, 2000

View: 2662 Download: 17

3

Clinical Features of Liver Abscess Developed after Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma

Min Hyung Kim, M.D., Moon Seok Choi, M.D., Yong Sung Choi, M.D., Do Young Kim, M.D., Ji Min Lee, M.D. Seung Woon Paik, M.D., Joon Hyuek Lee, Kwang Cheol Koh, M.D., Byung Cheol Yoo, M.D., Dongil Choi, M.D. and Jong Chul Rhee

Clin Mol Hepatol. 2006;12(1):55-64. Published online January 1, 1970

View: 3419 Download: 42

1 |

Viewed By 5662	MAFLD: How is it different from NAFLD?
Viewed By 5579	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5384	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5334	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4984	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 119	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 91	MAFLD: How is it different from NAFLD?
Cited By 82	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search